These effects have been linked to the interaction between the ERBB2 (HER2) receptor and MEMO1, which in turn was proposed to relay the activation of ERBB receptor heterodimers to the microtubule cytoskeleton, thus inducing growth of lamellipodia and enabling cancer cell migration (Marone et al., 2004). This evidence concerns the gene ERBB2 and cancer.